Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
NRG258 是一项随机 III 期试验,比较放化疗与单纯化疗治疗局部晚期子宫内膜癌的疗效,本研究的长期随访和总生存期如下:
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.01121
Matei, Daniela E; Enserro, Danielle M; Randall, Marcus E; Mutch, David; Small, William; DiSilvestro, Paul A; Spirtos, Nick M; O'Malley, David M; Cantuaria, Guilherme H; Michelin, David; Waggoner, Steven; Shahin, Mark; Guntupalli, Saketh; Lara, Olivia; Ueland, Frederick R; Warshal, David; Bonebrake, Albert; Tewari, Krishnansu S; Tan, Annie; Powell, Matthew A; Walker, Joan L; Santin, Alessandro D; Kim, Jong Hyeok; Miller, David S